Sylvain Auvity

749 total citations
40 papers, 544 citations indexed

About

Sylvain Auvity is a scholar working on Oncology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Sylvain Auvity has authored 40 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Cellular and Molecular Neuroscience and 8 papers in Neurology. Recurrent topics in Sylvain Auvity's work include Drug Transport and Resistance Mechanisms (14 papers), Neuroscience and Neuropharmacology Research (7 papers) and Epilepsy research and treatment (7 papers). Sylvain Auvity is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Neuroscience and Neuropharmacology Research (7 papers) and Epilepsy research and treatment (7 papers). Sylvain Auvity collaborates with scholars based in France, Austria and Portugal. Sylvain Auvity's co-authors include Nicolas Tournier, Fabien Caillé, Sébastien Goutal, Irène Buvat, Salvatore Cisternino, Bertrand Kühnast, Solène Marie, Oliver Langer, Wadad Saba and Michel Bottlaender and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Controlled Release and Neuropsychopharmacology.

In The Last Decade

Sylvain Auvity

40 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sylvain Auvity France	15	242	149	106	83	80	40	544
Candace Graff United States	10	343 1.4×	189 1.3×	201 1.9×	53 0.6×	78 1.0×	15	983
Pamela L. Golden United States	14	319 1.3×	204 1.4×	269 2.5×	72 0.9×	70 0.9×	28	1.2k
Kouichi Kawazu Japan	13	169 0.7×	113 0.8×	188 1.8×	46 0.6×	22 0.3×	29	616
David Dickens United Kingdom	14	192 0.8×	106 0.7×	185 1.7×	45 0.5×	59 0.7×	19	507
Carol Donovan United States	14	226 0.9×	44 0.3×	350 3.3×	40 0.5×	70 0.9×	20	996
Nathan S. Teuscher United States	10	176 0.7×	96 0.6×	100 0.9×	13 0.2×	59 0.7×	25	448
J. Nilsson Sweden	14	157 0.6×	63 0.4×	251 2.4×	102 1.2×	35 0.4×	22	806
Andrew Taku United States	7	194 0.8×	148 1.0×	71 0.7×	30 0.4×	76 0.9×	8	334
Scott M. Ocheltree United States	11	220 0.9×	96 0.6×	93 0.9×	87 1.0×	14 0.2×	12	454
Wendy Luo United States	16	73 0.3×	110 0.7×	262 2.5×	20 0.2×	72 0.9×	34	823

Countries citing papers authored by Sylvain Auvity

Since Specialization

Citations

This map shows the geographic impact of Sylvain Auvity's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Auvity with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Auvity more than expected).

Fields of papers citing papers by Sylvain Auvity

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvain Auvity. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Auvity. The network helps show where Sylvain Auvity may publish in the future.

Co-authorship network of co-authors of Sylvain Auvity

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvain Auvity. A scholar is included among the top collaborators of Sylvain Auvity based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvain Auvity. Sylvain Auvity is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cisternino, Salvatore, et al.. (2024). Formulation and Stability of a 1% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers?. Pharmaceuticals. 17(6). 691–691. 2 indexed citations

Auvity, Sylvain, et al.. (2024). Forecasting the potential impact of cell and gene therapies in France: projecting product launches and patients treated. Frontiers in Medicine. 11. 1324602–1324602. 3 indexed citations

Vodovar, Dominique, Solène Marie, Sylvain Auvity, et al.. (2023). Parametric Imaging of P-Glycoprotein Function at the Blood–Brain Barrier Using kE,brain-maps Generated from [11C]Metoclopramide PET Data in Rats, Nonhuman Primates and Humans. Molecular Imaging and Biology. 25(6). 1135–1141. 3 indexed citations

Boulch, Morgane, Marine Cazaux, Alexis Cuffel, et al.. (2023). A major role for CD4+ T cells in driving cytokine release syndrome during CAR T cell therapy. Cell Reports Medicine. 4(9). 101161–101161. 29 indexed citations

Leroy, Claire, Sébastien Goutal, Philippe Gervais, et al.. (2023). A pharmacological imaging challenge based on 11C-buprenorphine PET-MRI to explore the response to opioids in humans. European Journal of Nuclear Medicine and Molecular Imaging. 50(10). 3153–3154. 1 indexed citations

Gilbert, Alice, Armelle Rancillac, Audrey Chagnot, et al.. (2022). In mice and humans, brain microvascular contractility matures postnatally. Brain Structure and Function. 228(2). 475–492. 7 indexed citations

Auvity, Sylvain, Sébastien Goutal, Fabien Caillé, et al.. (2021). Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo. Neuropsychopharmacology. 46(6). 1220–1228. 14 indexed citations

Vidal, Fabrice, Romain Guéry, Sylvain Auvity, et al.. (2020). Voriconazole topical cream formulation: evidence for stability and antifungal activity. International Journal of Antimicrobial Agents. 56(3). 106083–106083. 10 indexed citations

Caillé, Fabien, Philippe Gervais, Sylvain Auvity, et al.. (2020). Automated two-step manufacturing of [11C]glyburide radiopharmaceutical for PET imaging in humans. Nuclear Medicine and Biology. 84-85. 20–27. 4 indexed citations

10.

Auvity, Sylvain, et al.. (2020). Assessment of practices for suspended oral drugs by tablet crushing in pediatric units. European Journal of Pharmaceutics and Biopharmaceutics. 157. 175–182. 15 indexed citations

11.

Bourasset, Fanchon, Sylvain Auvity, Robert G. Thorne, & Jean‐Michel Scherrmann. (2020). Brain Distribution of Drugs: Brain Morphology, Delivery Routes, and Species Differences. Handbook of experimental pharmacology. 273. 97–120. 6 indexed citations

12.

Tournier, Nicolas, Martin Bauer, Verena Pichler, et al.. (2019). Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate ¹¹C-Metoclopramide Assessed with PET Imaging in Humans. Journal of Nuclear Medicine. 60(7). 985–991. 38 indexed citations

13.

Auvity, Sylvain, Mattéo Tonietto, Fabien Caillé, et al.. (2019). Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB. European Journal of Nuclear Medicine and Molecular Imaging. 47(2). 490–501. 42 indexed citations

14.

Goutal, Sébastien, Sylvain Auvity, Fabien Caillé, et al.. (2018). Physical blood-brain barrier disruption induced by focused ultrasound does not overcome the transporter-mediated efflux of erlotinib. Journal of Controlled Release. 292. 210–220. 39 indexed citations

15.

Goutal, Sébastien, Solène Marie, Fabien Caillé, et al.. (2018). Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in rats. EJNMMI Research. 8(1). 81–81. 12 indexed citations

16.

Goutal, Sébastien, Oliver Langer, Sylvain Auvity, et al.. (2018). Intravenous infusion for the controlled exposure to the dual ABCB1 and ABCG2 inhibitor elacridar in nonhuman primates. Drug Delivery and Translational Research. 8(3). 536–542. 8 indexed citations

17.

Damont, Annelaure, Sébastien Goutal, Sylvain Auvity, et al.. (2016). Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [11C]-N-desmethyl-loperamide PET study in nonhuman primates. European Journal of Pharmaceutical Sciences. 91. 98–104. 10 indexed citations

18.

Auvity, Sylvain, Sébastien Goutal, Benoît Thezé, et al.. (2016). Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal. Drug and Alcohol Dependence. 170. 43–50. 11 indexed citations

19.

Tournier, Nicolas, Sébastien Goutal, Sylvain Auvity, et al.. (2016). Strategies to Inhibit ABCB1- and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood–Brain Barrier: A PET Study on Nonhuman Primates. Journal of Nuclear Medicine. 58(1). 117–122. 46 indexed citations

20.

Pottier, Géraldine, Solène Marie, Sébastien Goutal, et al.. (2015). Imaging the Impact of the P-Glycoprotein (ABCB1) Function on the Brain Kinetics of Metoclopramide. Journal of Nuclear Medicine. 57(2). 309–314. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact